The burden of multiple sclerosis variants in continental Italians and Sardinians

Multiple Sclerosis

Volumn 21, Issue 11, 2015, Pages 1385-1395

  Sanna, Serena ^b   Barizzone, Nadia ^a   Zara, Ilenia ^c   Sorosina, Melissa ^d   Lupoli, Sara ^f   Porcu, Eleonora ^b,g   Pitzalis, Maristella ^b   Zoledziewska, Magdalena ^b   Esposito, Federica ^d   Leone, Maurizio ^a,j   Mulas, Antonella ^b,g   Cocco, Eleonora ⁱ   Ferrigno, Paola ^e   Guerini, Franca R ^h   Brambilla, Paola ^d   Farina, Gabriele ^g   Murru, Raffaele ⁱ   Deidda, Francesca ^b   Sanna, Sonia ^b   Loi, Alessia ^b,g   Barlassina, Cristina ^f   Vecchio, Domizia ^a   Zauli, Andrea ^d   Clarelli, Ferdinando ^d   Braga, Daniele ^f   Poddie, Fausto ^g   Cantello, Roberto ^a   Martinelli, Vittorio ^d   Comi, Giancarlo ^d   Frau, Jessica ⁱ   Lorefice, Lorena ⁱ   Pugliatti, Maura ^g   Rosati, Giulio ^g   Melis, Maurizio ^e   Marrosu, Maria G ⁱ   Cusi, Daniele ^f   Cucca, Francesco ^b,g   Martinelli Boneschi, Filippo ^d   D'Alfonso, Sandra ^a   more..

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CNR   (Italy)

^c CENTER FOR ADVANCED STUDIES   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e BROTZU HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF SASSARI   (Italy)

^h IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

ⁱ UNIVERSITY OF CAGLIARI   (Italy)

^j CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

more..

Author keywords

Autoimmune disease; epidemiology; genetic risk score; genetics; human leukocyte antigen; Italy; Mediterranean populations; multiple sclerosis; Sardinia

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; EUROPE; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HLA SYSTEM; HUMAN; ITALIAN (CITIZEN); ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION GENETICS; POPULATION RESEARCH; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SARDINIA; SARDINIAN; SCORING SYSTEM; SOUTHERN EUROPEAN; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL MARKER; HLA ANTIGEN;

BIOMARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; ITALY; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84943164376     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515596599     Document Type: Article

References (35)

1. Patsopoulos NA, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897-912.
2. Sanna S, Pitzalis M, Zoledziewska M, et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 2010; 42: 495-497.
3. International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2, Sawcer S, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476: 214-219.
4. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-1360.
5. De Jager PL, Chibnik LB, Cui J, et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score. Lancet Neurol 2009; 12: 1111-1119.
6. Gourraud PA, McElroy JP, Caillier SJ, et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 2011; 69: 65-74.
7. Isobe N, Gourraud PA, Harbo HF, et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology 2013; 81: 219-227.
8. Isobe N, Madireddy L, Khankhanian P, et al. An ImmunoChip study of multiple sclerosis risk in African Americans. Brain Brain 2015; 138: 1518-30.
9. Novembre J, Johnson T, Bryc K, et al. Genes mirror geography within Europe. Nature 2008; 456: 98-101.
10. Marrosu MG, Murru R, Murru MR, et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001; 10: 1296-2907.
11. Ballerini C, Guerini FR, Rombolà G, et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 2004; 150: 178-185.
12. Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13: 700-722.
13. Ristori G, Cannoni S, Stazi MA, et al. Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study. Ann Neurol 2006; 59: 27-34.
14. Hadjixenofontos A, Gourraud PA, Bakthavachalam V, et al. Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia. Mult Scler 2015. DOI: 10.1177/1352458515581872.
15. Salvi E, Kutalik Z, Glorioso N, et al. Genome-wide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension 2012; 59: 248-255.
16. Corrado L, Bergamaschi L, Barizzone N, et al. Association of the CBLB gene with multiple sclerosis: New evidence from a replication study in an Italian population. J Med Genet 2011; 48: 210-211.
17. Coraddu F, Reyes-Yanez MP, Parra A, et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol 1998; 87: 130-135.
18. Allcock RJ, De la Concha EG, Fernandez-Arquero M, et al. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol 1999; 60: 1266-1273.
19. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, et al. HLA-DR and-DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997; 55: 59-65.
20. Carreras-Torres R, Kundu S, Zanetti D, et al. Genetic risk score of NOS gene variants associated with myocardial infarction correlates with coronary incidence across Europe. PLoS One 2014; 9: e96504.
21. Zhernakova A, Elbers CC, Ferwerda B, et al. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 2010; 86: 970-977.
22. Raj T, Kuchroo M, Replogle JM, et al. Common risk alleles for inflammatory diseases are targets of recent positive selection. Am J Hum Genet 2013; 92: 517-529.
23. Ramos PS, Shaftman SR, Ward RC, et al. Genes associated with SLE are targets of recent positive selection. Autoimmune Dis 2014; 2014: 203435.
24. Brinkworth JF, Barreiro LB., The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease. Curr Opin Immunol 2014; 31: 66-78.
25. Yarwood A, Han B, Raychaudhuri S, et al. A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk. Ann Rheum Dis 2015; 74: 170-6.
26. Romanos J, Rosen A, Kumar V, et al. Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2014; 63: 415-422.
27. Clayton DG., Prediction and interaction in complex disease genetics: Experience in Type 1 diabetes. PLoS Genet 2009; 5: e1000540.
28. Jostins L, Barrett JC., Genetic risk prediction in complex disease. Hum Mol Genet 2011; 20: R182-188.
29. Sawcer S, Ban M, Wason J, et al. What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010; 67: 3-10.
30. Wray NR, Yang J, Goddard ME, et al. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet 2010; 6: e1000864.
31. Kilpeläinen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children. PLoS Med 2011; 8: e1001116.
32. Langenberg C, Sharp SJ, Franks PW, et al. Gene-lifestyle interaction and Type 2 diabetes: The EPIC interact case-cohort study. PLoS Med 2014; 11: e1001647.
33. Marigorta UM, Gibson GA., Simulation study of gene-by-environment interactions in GWAS implies ample hidden effects. Front Genet 2014; 5: 225.
34. Patel CJ, Ioannidis JP., Studying the elusive environment in large scale. JAMA 2014; 311: 2173-2174.
35. Hu Y, Li L, Ehm MG, et al. The benefits of using genetic information to design prevention trials. Am J Hum Genet 2013; 92: 547-557.